ADVFN - Advanced Financial Network.
HOME» NYSE » F » FRX Stock Price » FRX Stock News

Forest Labs Share News

 Forest Laboratories, Inc. Stock Price
FRX Stock Price
 Forest Laboratories, Inc. Stock Chart
FRX Stock Chart
 Forest Laboratories, Inc. Stock News
FRX Stock News
 Forest Laboratories, Inc. Company Information
FRX Company Information
 Forest Laboratories, Inc. Stock Trades
FRX Stock Trades

Forest Labs: Icahn Nominates Four To Board, Holds 6.5% Stake

DOW JONES NEWSWIRES Forest Laboratories Inc. (FRX) said it received notice that one of billionaire activist investor Carl C. Icahn's affiliates intends to nominate four candidates for Forest's nine-member board. "While we have not yet had a chance to meet with Mr. Icahn to discuss his ideas for the company, we welcome constructive input from all of our shareholders," said Chairman and Chief Executive Howard Solomon. All of the directors are up for re-election and the pharmaceutical company said its nominating and governance committee will evaluate the nominees and make a recommendation. Icahn is well known for his efforts to push for change in boardrooms. Some of his more recent targets include Mentor Graphics Corp. (MENT) and Dynegy Inc. (DYN). High River L.P.'s slate includes Alexander J. Denner, a managing director of entities that advise Icahn-managed hedge funds; Dr. Richard Mulligan of the Harvard Medical School; Lucian A. Bebchuk, professor of law, economics, and finance and director of the program on corporate governance at Harvard Law School; and Dr. Eric J. Ende. High River also informed Forest Labs that it and affiliated entities own about 6.5% of the company's stock outstanding. Forest Labs made headlines in late April when it was reported the Department of Health and Human Services intended to exclude Solomon from doing business with the federal government, which could prevent Forest Labs from selling its drugs to the government--a major customer of all drug companies. Like many drug makers, Forest Labs has sought to partner with drug developers to bolster its pipeline. The company recently completed its $1.2 billion acquisition of Clinical Data Inc. (CLDA) in a bet that antidepressant Viibryd can help offset the looming loss of patent protection for Forest Lab's Lexapro, a depression treatment and its main money maker, and Alzheimer's drug Namenda. The company also reported in April its fiscal fourth-quarter earnings soared, absent prior-year licensing costs, as revenue rose 7.8%. Shares closed at $37.95 Friday and were inactive premarket. The stock has risen 47% over the past year. -By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Stock News for Forest Labs (FRX)
DateTimeHeadline
03/31/201409:18:21U.S. Hot Stocks: Hot Stocks to Watch
02/25/201407:20:12TPG 'Contemplating' Going Public
02/24/201417:01:35MARKET SNAPSHOT: Stocks Rally; S&P 500 Ends Right Below Record
02/24/201413:53:12MARKET SNAPSHOT: U.S. Stocks Rally As S&P 500 Hits Intraday Record
02/24/201405:47:09MARKET SNAPSHOT: U.S. Stock Market Is Starting To Ride A Tech...
02/18/201416:54:11MARKET SNAPSHOT: U.S. Stocks Edge Up; Nasdaq Gains For 8th Day...
02/18/201415:35:34MARKET SNAPSHOT: U.S. Stocks Churn; Coke Weighs On Dow, Nasdaq...
02/18/201411:32:36MARKET SNAPSHOT: U.S. Stock Gains Muted By Data; Coke Weighs...
02/18/201411:04:34MARKET SNAPSHOT: U.S. Stocks Edge Lower After Weak Data
02/18/201410:16:54MARKET SNAPSHOT: U.S. Stocks Edge Higher; Manufacturing Data...
01/21/201417:07:35MARKET SNAPSHOT: U.S. Stocks Close Higher; Earnings Misses Drag...
01/21/201412:37:10MARKET SNAPSHOT: U.S. Stocks Rise On China; J&J Drags On Dow
01/08/201416:40:12MARKET SNAPSHOT: U.S. Stocks End Lower After Fed Minutes
01/08/201414:47:17MARKET SNAPSHOT: U.S. Stocks Hold Losses After Fed Minutes
01/08/201412:31:37MARKET SNAPSHOT: U.S. Stocks Seesaw Ahead Of Fed Minutes
01/08/201410:18:10MARKET SNAPSHOT: U.S. Stocks Drop Ahead Of Fed Minutes
12/02/201315:08:00Forest Labs Unveils Restructuring
11/15/201308:22:25Janus Capital Management 3Q 13F: Largest Purchases -2-
11/15/201308:22:24Janus Capital Management 3Q 13F: Largest Purchases
11/15/201308:10:03Icahn Associates Corp. 3Q 13F: Holdings As Of Sep 30

Forest Labs and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad